Cite
HARVARD Citation
Rizzieri, D. et al. (n.d.). A phase II study of elacytarabine in combination with idarubicin and of human equilibrative nucleoside transporter 1 expression in patients with acute myeloid leukemia and persistent blasts after the first induction course. Leukemia & lymphoma. 55 (9), pp. 2114-2119. [Online].